In a recent paper published by the Paragon Health Institute, Duke Health's Chief Data Scientist Michael Pencina, PhD, and Paragon Research Fellow Kev Coleman chart a path toward responsible AI implementation, monitoring, and review in healthcare. The paper highlights the importance of private sector collaboration with the FDA on postmarket surveillance of AI tools, and outlines strategies to mitigate risks from unpredictable outputs, advancing safe, secure, and reliable AI in U.S. healthcare.
Read here: https://paragoninstitute.org/private-health/targeted-postmarket-surveil…